Business
Exercise of Warrants and Issue of Shares
Exercise of Warrants and Issue of Shares.
About this update from Hvivo Plc
[{"type":"text","content":"\n \nRNS Number : 0565C Open Orphan PLC 05 February 2020 \n\n5 February 2020\nOpen Orphan Plc\n(\"Open Orphan\" or the \"Company\")\n \nExercise of Warrants and Issue of Shares\n \nTotal Voting Rights\n \nOpen Orphan plc (ORPH), a rapidly growing specialist pharmaceutical services company which has a focus on orphan drugs, announces that the Company has received notices of exercise of warrants over 539,654 ordinary shares of 0.1 pence each in the capital of the Company (\"Ordinary Shares\") at a price of 0.1 pence per share for 191,051 Ordinary Shares and at a price of 2.2 pence per share for 348,603 Ordinary Shares. The gross proceeds of this exercise received by the Company amounts to £7,860.33.\n \nFollowing the warrant exercise, the outstanding warrants over Ordinary Shares are as follows:\n \n\n\n\n\nNumber of Ordinary Shares\n\n\nExercise Price per share\n\n\nExpiry Date\n\n\n\n\n166,666\n\n\n30 pence\n\n\n6 June 2021\n\n\n\n\n1,568,701\n\n\n0.1 pence\n\n\n10 December 2023\n\n\n\n\n2,862,337\n\n\n2.2 pence\n\n\n10 December 2023\n\n\n\n\n1,607,142\n\n\n5.6 pence\n\n\n27 June 2024\n\n\n\n\n\nThe Company has made application for 539,654 new Ordinary Shares, to be issued and allotted as a result of the warrant exercise set out above, to be admitted to trading on AIM and Euronext Growth. Admission is expected to occur at 8.00 a.m. on 11 February 2020.\n \nTotal Voting Rights\nFollowing the admission of 86,885,253 new Ordinary Shares in connection with the placing and subscription announced by the Company on 31 January 2020, which is expected to occur at 8.00 a.m. on 6 February 2020, and the admission of 539,654 new Ordinary Shares issued and allotted as a result of the warrant exercise set out above, which is expected to occur at 8.00 a.m. on 11 February 2020, the Company's total issued ordinary share capital will consist of 533,047,281 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.\n \nEnquiries:\nOpen Orphan Plc Tel: +353 1 644 0007\nCathal Friel, Executive Chairman\nTrevor Phillips, Chief Executive Officer Tel: +44 (0)2...